SAN DIEGO–(BUSINESS WIRE)–Clarify Medical today announced the appointment of Andrew Cohen as its Vice President of Marketing, effective immediately. Mr. Cohen has more than 18 years of U.S. and international marketing experience in the life sciences, medical device, and clinical diagnostics industries. Throughout his career, he has held senior commercial positions at Advanced BioHealing Inc., Nuo Therapeutics, Millennium Laboratories, and Organogenesis.
“Andrew’s extensive experience marketing innovative medical technologies to both healthcare professional and patients will be a major contributor to our marketing efforts,” said George Mahaffey, President and CEO of Clarify Medical. “One crucial aspect of Andrew’s role will be to continue developing programs to educate the U.S. medical dermatology community that they can effectively follow the recently published Joint American Academy of Dermatology – National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy by using the Clarify Home Phototherapy System.
The Clarify System, which has been cleared by the FDA, is indicated for localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of targeted narrowband UVB (NB-UVB) light therapy; the System helps to ensure that patients receive the proper doses recommended by the American Academy of Dermatology in its published Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis and The Vitiligo Working Group Recommendations for NarrowBand Ultraviolet B Light Phototherapy Treatment of Vitiligo.
The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer precision treatment and achieve clinical efficacy in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress and satisfaction.
The Clarify smartphone app syncs to a patented, lightweight, handheld device which guides patients through delivering targeted narrowband UVB phototherapy treatments for their specific skin conditions. All treatment records, including photographs and patient-reported outcomes, are available to both the patient and the physician and can be used for evaluation during follow-up visits. Clarify CarePartners, trained patient support personnel, act as the first line of support for patients – coaching them on the use of the system and encouraging treatment adherence – greatly reducing the burden of these functions on the physician’s practice.
“There is a tremendous market opportunity here to provide a safe, effective, and convenient treatment alternative for patients with chronic skin conditions and their healthcare providers – all while reducing costs to the overall healthcare system,” said Mr. Cohen. “I’m very excited to join the Clarify Medical team and start building awareness of this innovative home treatment system.”
About Clarify Medical, Inc.
Clarify Medical is a private San Diego-based medical device company focused on developing innovative technology, products and services that improve care for people with chronic skin conditions. Its Clarify Home Phototherapy System is now available nationally in the U.S. Learn more at www.clarifymed.com.
Media Contact: Teddy Fulham, 626-823-6744, firstname.lastname@example.org